From: Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers
Patients n = 27
M/F
18/9
Age at diagnosis [median]
27,4
Disease duration [years, mean (SD)]
6,1 (2,2)
Disease location
-Rectum
0
-Sigmoid/Left colon
9
-Transverse colon
3
-Right colon
-Ileum
27
Anti-TNF drugs
-IFX
18
-ADA